The company currently has 22 projects in its portfolio for the…
The company currently has 22 projects in its portfolio for the development of original molecules and bioanalogues for the therapy of oncological, autoimmune, and neurodegenerative diseases.
Coverage (2 sources)
- In Moscow, 11 new molecules are being developed for the treatment of cancer and autoimmune diseases — Московские новости
- In Moscow, 11 biomolecules will be developed for therapy of oncological and autoimmune diseases — Москва 24